Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Roivant Sciences Ltd. Common Shares (ROIV) vs Spotify Technology (SPOT) Price & Performance

Roivant Sciences Ltd. Common SharesTrade
Spotify TechnologyTrade

Price performance (Past 24H)

Key statistics

Roivant Sciences Ltd. Common Shares vs Spotify Technology — how do they compare? Roivant Sciences Ltd. Common Shares trades at $34.21 (market cap $25.09B), while Spotify Technology trades at $527.49 (market cap $105.45B). The key difference: Spotify Technology is far larger — about 4.2× Roivant Sciences Ltd. Common Shares's market cap, and Roivant Sciences Ltd. Common Shares is trading nearer its 52-week high, Spotify Technology nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Roivant Sciences Ltd. Common Shares for 0 Days and Spotify Technology for 111 Days on average.

ROIVSPOT
Market Cap
$25.09B$105.45B
Volume
5,738,5712,000,851
Sector
HealthMedia
52-Week High
$41.81$692.04
52-Week Low
$16.04$412.75
Typical Hold Time
0 Days111 Days
Enterprise Value
$21.36B$95.41B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Roivant Sciences Ltd. Common Shares

No Aura AI signal available yet.

Spotify Technology

Spotify (SPOT) trades at $526.42, up 7.84% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with revenue growth from $15.7B to $17.2B in 2025 and net income surging to $2.2B. Recent Q2 2026 earnings missed expectations, but analyst consensus remains strongly bullish with a $610 price target. Technical indicators show support at $497 and resistance at $524, with the stock approaching key resistance levels.

Spotify presents a compelling growth story with expanding profit margins and strong cash flow generation. The primary investment opportunity lies in continued subscriber growth and margin expansion, though risks include competitive pressures in streaming and execution challenges. Wall Street maintains strong conviction with 62% buy ratings, suggesting 16% upside to consensus targets.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

ROIV
100% Buy0% Sell
Avg holding period · 0 Days
SPOT
33% Buy67% Sell
Avg holding period · 111 Days

Top news

Latest headlines on both assets

About Roivant Sciences Ltd. Common Shares

Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.

Read more on ROIV →

About Spotify Technology

Spotify Technology S.A. provides music streaming services. The Company offers commercial-free music and ad-supported services to subscribers. Spotify Technology serves clients worldwide.

Read more on SPOT →